Nosocomial Acinetobacter pneumonia

Respirology

Volumn 12, Issue 6, 2007, Pages 787-791

  Luna, Carlos M ^a,b   Aruj, Patricia K ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b NONE   (Argentina)

Author keywords

Acinetobacter; Multi drug resistant; Nosocomial pneumonia; Ventilator associated pneumonia

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; CARBAPENEM; CILASTATIN PLUS IMIPENEM; COLISTIN; RIFAMPICIN; SULBACTAM; SULTAMICILLIN; TIGECYCLINE; TOBRAMYCIN; VANCOMYCIN;

ACINETOBACTER; ACINETOBACTER BAUMANNII; ACINETOBACTER CALCOACETICUS; ANTIMICROBIAL ACTIVITY; ANTIMICROBIAL THERAPY; BACTERIAL COLONIZATION; BACTERIAL INFECTION; BACTERIAL STRAIN; HOSPITAL INFECTION; HUMAN; INFECTION PREVENTION; INFECTION RISK; PNEUMONIA; PRIORITY JOURNAL; PSEUDOMONAS; REVIEW; STATISTICAL SIGNIFICANCE;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; COMORBIDITY; DRUG RESISTANCE, MICROBIAL; DRUG THERAPY, COMBINATION; HUMANS; LENGTH OF STAY; PNEUMONIA, BACTERIAL; PNEUMONIA, VENTILATOR-ASSOCIATED; RISK FACTORS;

EID: 35748968458     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2007.01147.x     Document Type: Review

References (27)

1. Bouvet PJM, Grimont PAD. Identification and biotyping of clinical isolates of Acinetobacter. Ann. Inst. Pasteur Microbiol. 1987 138 : 569 78.
2. Van Looveren M, Goossens H, ARPAC Steering Group. Antimicrobial resistance of Acinetobacter spp. in Europe. Clin. Microbiol. Infect. 2004 10 : 684 704.
3. Urban C, Maurer-Segal Rahal JJ. Considerations in control and transmission of nosocomial infections due to multi-drug resistant Acinetobacter baumannii. Clin. Infect. Dis. 2003 36 : 1268 74.
4. Musa EK, Desai N, Casewell MW. The survival of Acinetobacter calcoaceticus inoculated on fingertips and on Formica. J. Hosp. Infect. 1990 1 : 219 27.
5. Wendt C, Dietze B, Ruden H. Survival of Acinetobacter species on dry surfaces. J. Clin. Microbiol. 1997 35 : 1394 7.
6. Bergogne-Berezin E, Towner KJ. Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin. Microbiol. Rev. 1996 9 : 148 65.
7. Seifert H, Baginsky R, Schulze A, Pulverer G. The distribution of Acinetobacter species in clinical culture materials. Zentralbl. Bakteriol. 1993 279 : 544 52.
8. Baumann P, Doudoroff M, Stanier RY. A study of the Moraxella group. II. Oxidase-negative species (genus Acinetobacter). J. Bacteriol. 1968 95 : 1520 41.
9. Rello JSa, Borges M, Correa H, Leal SR, Baraibar J. Variations in etiology of ventilator-associated pneumonia across four treatment sites: implications for antimicrobial prescribing practices. Am. J. Respir. Crit. Care Med. 1999 160 : 608 13.
10. Luna CM, Monteverde A, Rodriguez A, Apezteguia C, Zabert G et al. Clinical Guidelines for the Treatment of Nosocomial Pneumonia in Latin America: an Interdisciplinary Consensus Document. Arch. Bronconeumol. 2005 41 : 439 56.
11. Luna CM, Vujacich P, Niederman MS, Vay C, Gherardi C et al. Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia. Chest 1997 111 : 676 85.
12. Torres A, Aznar R, Gatell JM, Jimenes P, Gonzalez J et al. Incidence, risk and prognosis factors of nosocomial pneumonia in mechanically ventilated patients. Am. Rev. Respir. Dis. 1990 142 : 523 8.
13. Garnacho-Montero J, Ortiz-Leyba C, Fernandez-Hinojosa E, Aldabo-Pallas T, Cayuela A et al. Acinetobacter baumannii ventilator-associated pneumonia: epidemiological and clinical findings. Intensive Care Med. 2005 31 : 649 55.
14. Bergogne-Berezin E, Joly-Guillou ML. Hospital infection with Acinetobacter spp. an increasing problem. J. Hosp. Infect. 1991 18 (Suppl. A 250 5.
15. Fagon JY, Chastre J, Domart Y, Trouillet JL, Pierre J et al. Nosocomial pneumonia in patients receiving continuous mechanical ventilation: prospective analysis of 52 episodes with use of a protected specimen brush and quantitative culture techniques. Am. Rev. Respir. Dis. 1989 139 : 877 84.
16. Fagon JY, Chastre J, Hance AJ, Montravers P, Novara A et al. Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay. Am. J. Med. 1993 94 : 281 8.
17. Falagas ME, Kopterides P. Risk factors for the isolation of multi-drug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa: A systematic review of the literature. J. Hosp. Infect. 2006 64 : 7 15.
18. Cisneros-Herreros JM, Garnacho-Montero J, Pachon-Ibanez ME. Nosocomial pneumonia due to Acinetobacter baumannii. Enferm. Infecc. Microbiol. Clin. 2005 23 (Suppl. 3 46 51.
19. Playford EG, Craig JC, Iredell JR. Carbapenem-resistant Acinetobacter baumannii in intensive care unit patients: Risk factors for acquisition, infection and their consequences. J. Hosp. Infect. 2007 65 : 204 11.
20. Mueller EW, Hanes SD, Croce MA, Wood GC, Boucher BA et al. Effect from multiple episodes of inadequate empiric antibiotic therapy for ventilator-associated pneumonia on morbidity and mortality among critically ill trauma patients. J. Trauma 2005 58 : 94 101.
21. Murray CK, Hospenthal DR. Treatment of multidrug resistant Acinetobacter. Curr. Opin. Infect. Dis. 2005 6 : 502 6.
22. Rios FG, Luna CM, Maskin B, Saenz Valiente A, Lloria M et al. Ventilator-associated pneumonia (VAP) due to susceptible only to colistin microorganisms. Eur. Respir. J. 2007 30 : 307 13.
23. Reina R, Estenssoro E, Saenz G, Canales HS, Gonzalvo R et al. Safety and efficacy of colistin in Acinetobacter and Pseudomonas infections: a prospective cohort study. Intensive Care Med. 2005 31 : 1058 65.
24. Vidaur L, Sirgo G, Rodriguez AH, Rello J. Clinical approach to the patient with suspected ventilator-associated pneumonia. Respir Care. 2005 50 : 965 74.
25. Montero A, Ariza J, Corbella X, Domenech A, Cabellos C et al. Efficacy of colistin versus beta-lactams, aminoglycosides, and rifampin as monotherapy in a mouse model of pneumonia caused by multiresistant Acinetobacter baumannii. Antimicrob. Agents Chemother. 2002 46 : 1946 52.
26. Jeong SH, Bae IK, Kwon SB, Lee K, Yong D et al. Investigation of a nosocomial outbreak of Acinetobacter baumannii producing PER-1 extended-spectrum b-lactamase in an intensive care unit. J. Hosp. Infect. 2005 59 : 242 8.
27. Pimentel JD, Low J, Styles K, Harris OC, Hughes A et al. Control of an outbreak of multi-drug resistant Acinetobacter baumannii in an intensive care unit and a surgical ward. J. Hosp. Infect. 2005 59 : 249 53.